Issuer positions
1
Reporting Owner Activity for NOVARTIS PHARMA AG
Form 3/4/5 issuer positions and transaction evidence for this reporting owner.
Largest position
PRECISION BIOSCIENCES INC
Disclosed value
$4.59M
Recent activity
Available
- Forms 3/4/5 ownership summary
-
Estimated owner position value
$4,590,753
Estimated from parsed Forms 3/4/5 when the filing discloses enough holding data.
Issuer positions
1
Distinct issuers tied to this reporting owner in parsed SEC filings.
Largest issuer position
PRECISION BIOSCIENCES INC (DTIL)
$4.59M estimated from parsed owner filings.
Latest owner filing
27 Jun 2022
Most recent owner-level filing date in the parsed SEC record.
How to read Forms 3/4/5 positions
- Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough pricing and share data.
- Verify the source filing before treating any owner position as current.
- Location
- Basel, Switzerland
- SEC signature
- Novartis Pharma AG /s/ Christian Rehm, Authorized Signatory /s/ Lukas Foertsch, Authorized Signatory
- Source evidence
- Open source filing history
SEC ownership signals
1 fact
Identity
1 fact
SEC filing record
1 fact
SEC evidence
1 fact
Follow Filing Activity
Follow NOVARTIS PHARMA AG and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for NOVARTIS PHARMA AG
DTIL
Forms 3/4/5
PRECISION BIOSCIENCES INC
- Relationship
- 10%+ Owner
- Holdings value
- $4,590,753
- Past year net change
- Change %
- Report period
- 15 Jun 2022
Recent insider transactions for NOVARTIS PHARMA AG
| Sym | Company | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.